Dr. William J Dierberg, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 |
Dr. James Lee, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 704 S Webster Ave, Ste 401, Green Bay, WI 54301 Phone: 920-436-8284 |
Steven C Schmidt, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 Fax: 920-288-8255 |
Dr. Elizabeth A O'connor, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 Fax: 920-288-8255 |
Dr. Eugene H Schmitt Iii, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 704 S Webster Ave, Ste 401, Green Bay, WI 54301 Phone: 920-432-7000 Fax: 920-432-7451 |
James M Zasuly, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 Fax: 920-857-1488 |
News Archive
New research findings published in the March issue of the Journal of the American College of Surgeons indicates that despite similar injury severity, uninsured patients were significantly more likely to die after hospital admission for gunshot injury than were insured patients. This difference could not be attributed to demographics or hospital resource use, and held true even after adjusting for the effects of race, age, gender, and injury severity.
Nicotine-free plastic inhalers may increase a smoker's chance of quitting, according to new research published online in the European Respiratory Journal.
Researchers have developed a method to swiftly screen the non-coding DNA of the human genome for links to diseases that are driven by changes in gene regulation.
A team of researchers at the University of California, Riverside, used automated computer methods to mine a large online discussion forum for electronic cigarette users and found this group reported numerous adverse health effects for at least seven years.
NABsys Inc., the pioneer in electronic, solid-state DNA sequencing, today announced that it has received a $7 million investment as part of a Series B equity round led by Stata Venture Partners. The funding will be used to accelerate the development and commercialization of the company's proprietary DNA sequencing platform, which leverages semiconductor technology to achieve the scope and scale required for full integration of genomics into medicine.
› Verified 2 days ago